The doctor was very thorough and asked…
The doctor was very thorough and asked me alot of questions. Very polite and genuinely concerned about the situation. I am very impressed and thankful for the visit
Ubrelvy (ubrogepant) is a prescription migraine treatment that targets the root cause of attacks. Get evaluated online and, if appropriate, receive a prescription without leaving home.
Chat for free, see an online doctor for $39/visit, or renew a prescription online for as low as $0
Start a Free Chat With Doctronic
Doctronic answers your health questions with personalized medical insights and helps our doctors create a better treatment plan for you.
Meet With a Licensed Doctor For Treatment
Book a $39 telehealth appointment (or copay), with an average wait of about 5 minutes. Our doctors create personalized treatment plans with prescriptions when needed.
Pick Up Your Prescription
Our doctors prescribe non-controlled medications in all 50 states and send prescriptions to your pharmacy for same-day pickup.
Ubrelvy (ubrogepant) is a prescription medication used to manage acute migraine attacks in adults. It works by blocking calcitonin gene-related peptide (CGRP) receptors, which play a central role in triggering migraine pain and associated symptoms. With the right dose and ongoing monitoring, most patients experience meaningful pain relief within two hours of taking a dose.
Doctronic can evaluate you for Ubrelvy (ubrogepant) if you are an adult with a confirmed or suspected diagnosis of migraine and are looking for an acute treatment option. Ubrelvy is intended for use at the onset of a migraine attack, not for daily preventive use.
Because Ubrelvy works through the CGRP pathway and is metabolized by the liver enzyme CYP3A4, your physician will review your full medication list, liver health history, and any history of severe hepatic impairment before prescribing. Patients currently taking strong CYP3A4 inhibitors or inducers may not be good candidates.
Ubrelvy is a CGRP receptor antagonist, meaning it blocks the protein (CGRP) responsible for triggering migraine pain rather than constricting blood vessels the way triptans do. This makes Ubrelvy a potential option for people who cannot tolerate triptans or have cardiovascular conditions that make vasoconstrictors unsuitable, though your physician will determine the best fit for you.
In clinical trials, a meaningful proportion of patients treated with Ubrelvy 100 mg achieved pain freedom at two hours compared to placebo. Individual results vary, and a second dose may be taken two hours after the first if the initial dose provides insufficient relief.
No. Ubrelvy is an acute treatment intended to stop a migraine once it has started, not a daily preventive medication. If you need preventive therapy, your Doctronic physician can discuss options such as rimegepant (Nurtec), which has an FDA-approved preventive indication, or other preventive agents.
Yes. Strong CYP3A4 inhibitors (such as certain antifungals and antibiotics) significantly increase ubrogepant levels in the blood, and strong CYP3A4 inducers (such as rifampin) reduce its effectiveness. You should provide your full medication list during your evaluation so your physician can identify any interactions.
The standard doses are 50 mg or 100 mg taken at the onset of a migraine attack. If symptoms persist, a second dose of the same strength may be taken at least two hours after the first dose. No more than two doses should be taken within any 24-hour period.
Unlike triptans, Ubrelvy does not cause vasoconstriction, so it does not carry the same cardiovascular restrictions. However, your physician will review your complete medical history before prescribing to ensure Ubrelvy is appropriate and safe for your individual situation.
Doctronic uses an AI-powered evaluation to gather detailed information about your symptoms and medical history. A licensed physician then reviews your case and, if clinically appropriate, creates a personalized treatment plan that may include a prescription sent directly to your preferred pharmacy.
Yes. Doctronic connects patients with fully licensed U.S. physicians who review and approve every treatment plan. The platform is HIPAA-aligned, and all clinical decisions are doctor-reviewed and audited to ensure the highest standards of safety and care.
People turn to Doctronic and our licensed medical team for support with all types of conditions.